Multicenter evaluation of the Panbio COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection.
Testing Method Category
Testing Method - Additional Info
Panbio COVID-19 Ag Rapid Test Device (PanbioRT) (Abbott)
sensitivity: 90.5% (overall), 99.5% (in patients with PCR Ct<25), 91.8% (< 5 dpo); specificity: 98.8%; agreement with PCR: 95.7%; NPV: 94.6%; PPV: 97.8%
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements